8-K current report · filed Oct 6, 2026

Beauty Health Co (SKIN) 8-K Current Report: October 6, 2026

Item 1.02Item 7.01SKIN overview

Short answer

Beauty Health Co (SKIN) filed an 8-K current report with the SEC on October 6, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure). $0 remaining 1.25% convertible senior notes due 2026 after full repayment on September 30, 2026.

Beauty Health Co 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.02 · Termination of a Material Definitive Agreement

  • $0 remaining 1.25% convertible senior notes due 2026 after full repayment on September 30, 2026
  • Accrued and unpaid interest paid alongside principal, eliminating the associated debt obligation
  • Indenture satisfied and discharged, releasing SkinHealth from remaining obligations except surviving provisions
  • Convertible-note overhang removed, reducing future refinancing and potential equity-dilution concerns

Item 7.01 · Regulation FD Disclosure

  • Notes fully retired on September 30, 2026, one day before scheduled October 1 maturity
  • $103.235M principal repayment, plus $645,218.75 accrued interest
  • Debt retirement removes the Notes from the company’s outstanding obligations
  • $103.235M cash outflow may reduce liquidity, with no refinancing details disclosed

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Beauty Health Co 8-K filings

Get the next SKIN 8-K as it lands

Follow SKIN for push alerts, or ask the research agent what this filing means.